NRx Pharmaceuticals (Nasdaq:NRXP) Welcomes Presidential Initiative to Accelerate Approval of Psychedelic Medications to Treat Depression, PTSD, and Suicidality

depression

NRx Pharmaceuticals (Nasdaq:NRXP) Welcomes Presidential Initiative to Accelerate Approval of Psychedelic Medications to Treat Depression, PTSD, and Suicidality

ONLY AVAILABLE IN PAID PLANS.

Originally reported by financialcontent. Read more

Source: https://www.financialcontent.com/article/gnwcq-2026-4-20-nrx-pharmaceuticals-nasdaqnrxp-welcomes-presidential-initiative-to-accelerate-approval-of-psychedelic-medications-to-treat-depression-ptsd-and-suicidality